Navigation Links
Whole grain diets lower risk of chronic disease
Date:2/5/2008

Diets with high amounts of whole grains may help achieve significant weight loss, and also reduce the risk of chronic diseases such as diabetes and cardiovascular disease, according to a team of Penn State researchers at University Park and the College of Medicine.

"Consumption of whole grains has been associated with a lower body weight and lower blood pressure," said co-author Penny Kris-Etherton, distinguished professor of nutritional sciences at Penn State. "We thought that incorporating whole grains into a heart-healthy weight loss diet may provide the same benefits to people at risk from chronic diseases."

The researchers recruited 50 obese adults 25 male and 25 female between ages 20 to 65 and known to have metabolic syndrome, a cluster of symptoms that increase the risk of developing cardiovascular disease and diabetes.

They were randomly assigned to either a group that received instructions to have all of their grain servings from whole grains or all of their grain servings from refined grains.

"We asked participants in the whole grain group to focus on foods that had whole grains as the first ingredient," said lead author Heather Katcher, a Penn State Ph.D. recipient and currently a dietetic intern at Tulane University.

Over the 12-week study period, all participants received the same dietary advice on weight loss, and encouragement to participate in moderate physical activity. Researchers also asked participants to consume five daily servings of fruits and vegetables, three servings of low-fat dairy products, and two servings of lean meat, fish or poultry.

The study's findings are published in the January 2008 issue of the American Journal of Clinical Nutrition.

Results from the study showed that waist circumference and body weight decreased significantly in both groups between 8-11 pounds on average but weight loss in the abdominal region was significantly greater in the whole grain group.

According
'/>"/>

Contact: Amitabh Avasthi
axa47@psu.edu
814-865-9481
Penn State
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Colorado Residents and Visitors to Investigate Health in a Whole New Way
2. Hidden Veggies on the go hits Whole Foods Market(R) in 2008
3. Kim & Scotts Gourmet Pretzels(R) Introduces Its First Empowered Pretzel(TM) Available Online and to Wholesale
4. A Whole New Sandwich Debuts in the Freezer Aisle: LEAN POCKETS(R) Brand Introduces Latest Whole Grain Varieties
5. Fitness Sensation Susan Powter Returns to Her Legions of Fans and Followers with Focus on Whole Body Wellness Program
6. AstraZeneca Response to November 2, 2007 Ruling In Re: Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, U.S. District Court, District of Massachusetts
7. Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case
8. Whole Grains Do a Heart Good
9. Whole Foods Market(R) Helps Shoppers Understand the Benefits of Natural Cosmetics
10. Whole Foods Market(R) Donates $25,000, for Midwest Farmers - Hoping to Match an Additional $10,000, via Customer Donations
11. Childs Flu Shot Helps Whole Family
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Whole grain diets lower risk of chronic disease
Whole grain diets lower risk of chronic disease
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...gist and a radiation oncologist at Memorial Sloan-...f the physician patients see can influence the ty...nalyzed men with localized prostate cancer. It fou...ologist are more likely to undergo surgery to remo...
...announced follow-up data from a Phase 2 clinical t...hich was conducted by the Johns Hopkins Sidney Kim... with operable pancreatic cancer who received GVAX...vant radiation and chemotherapy. The median overal...
...terpret confusing situations or those that may pos...rchers from the Mouse Biology Unit of the Europea...covered the neural basis for such anxiety behaviou...rent issue of Nature Neuroscience, states that cru...
...ve of the underdeveloped countries is old hat by n...ting hospital infection. Only a few days ago it wa...k patient in England complained he had been left l...few hours. But some time governments in the devel...
Other Medicine News:Health News:Early Prostate Cancer: Specialty of Physician Influences Type of Therapy Received 2Health News:Early Prostate Cancer: Specialty of Physician Influences Type of Therapy Received 3Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 3Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 4Health News:Neural Basis of Anxiety: Newer Insights 2Health News:Crackdown on Dirty Hospitals in UK 2Health News:Crackdown on Dirty Hospitals in UK 3
(Date:10/8/2008)...inical improvement in patients with pulmonary ...ent options have limited benefit for this debilita... vessel disease, -- Imatinib mesylate, availabl...ers, known to inhibit protein associated with PAH,...atinib mesylate in PAH in 2009 EAST HANOVER,...
(Date:10/7/2008)...wire/ -- The Texas Cardiac Arrhythmia,Institute (T...ed as one of,only a few sites in the nation to par...ew device to treat persistent atrial fibrillation....search center specializing in heart,rhythm disorde...enter and,Texas Cardiovascular Consultants., "Thi...
(Date:10/7/2008)...re-FirstCall/ -- CEL-SCI Corporation,(NYSE: CVM )...al Transfer,Agreement (MTA) with the National Inst...aboratory of Dr. Francesco M. Marincola, M.D., to,...tumor microenvironment,caused by CEL-SCI,s cancer ...Infectious Disease and Immunogentics Section, Depa...
(Date:10/7/2008)...ewswire/ -- Taligen Therapeutics Inc.,today announ...pipeline,candidates were presented at the XXII Int...nd. The data highlighted the candidates, efficacy ...seases., "These highlighted presentations, as wel...ference, reveal the deep expertise and expanding,k...
Breaking Medicine Technology:Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4Indonesias Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters 25770 1Indonesias Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters 25770 2Indonesias Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters 25770 3ORBIS and Alcon Train Chinas Next Generation of Sight Savers 7316 1ORBIS and Alcon Train Chinas Next Generation of Sight Savers 7316 2ORBIS and Alcon Train Chinas Next Generation of Sight Savers 7316 3ORBIS and Alcon Train Chinas Next Generation of Sight Savers 7316 4Lilly and Amylin Set Date and Time for Conference Call 25766 1Lilly and Amylin Set Date and Time for Conference Call 25766 2AgriLife Research breeder develops drought tolerant corn 4604 1AgriLife Research breeder develops drought tolerant corn 4604 2
... MINNEAPOLIS--(BUSINESS WIRE)--Mar 27, 2007 - Acco..., nearly 80 percent of the American,public does no...abetes. The survey, conducted by Harris Interactiv...), showed that almost half,of respondents were als...ted. The results of the survey, particularly those...
... LANSING, Mich., March 27, 2007 /PRNewswire/ -- A...positive results on,the ability of its new triple ...ections of mammalian cells. The audited results we...party testing,organization. The new viral sequestr...iruses by 3 critical mechanisms thus blocking,infe...
Other Medicine Technology:Survey Reveals Significant Public Lack of Diabetes Awareness 2Survey Reveals Significant Public Lack of Diabetes Awareness 3Survey Reveals Significant Public Lack of Diabetes Awareness 4Afid Therapeutics Obtains Positive Evaluation of its Triple Mode,Viral Sequestration Agents 2
Laser hair removal for all skin types, including tanned skin. Used for leg and facial veins, non-invasive skin treatment. Offers a large spot sizes with high repetition rates for fast treatment. A
The Soft THORACOPORT™ has a cannula that is less rigid from a side to side perspective than the standard THORACOPORT™ , ,THORACOPORT™ devices are trocars used to gain access to th
These are the Reusable Components (minus cannula), to be used with the VersaStep™ Plus Reposable Short System.
VersaStep™ Reposable Sterilization Trays.
Medicine Products: